A groundbreaking study has shed new light on the astonishing diversity of protein structures and their folds in nature.
Shifting the paradigm – novel approaches to amyotrophic lateral sclerosis therapy – Pharmaceutical Technology
Share this article The high failure rate in ALS clinical trials is often attributed to the disease’s unclear aetiology and complex pathophysiology. Credit: CC7 via